| JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | RVI BIOTECNOLOGÍA | 89,211728 | 23/07/2026 | 12,15% | 15,40% | ** |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | RVI BIOTECNOLOGÍA | 63,860604 | 23/07/2026 | 12,15% | 14,40% | ** |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 88,000000 | 23/07/2026 | 7,82% | 9,21% | ** |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | RVI BIOTECNOLOGÍA | 71,462430 | 23/07/2026 | 11,25% | 10,45% | ** |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 109,630000 | 23/07/2026 | 8,77% | 14,41% | ** |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | RVI BIOTECNOLOGÍA | 80,705758 | 23/07/2026 | 12,24% | 15,85% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | RVI BIOTECNOLOGÍA | 79,150000 | 23/07/2026 | 12,14% | 15,68% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 77,060000 | 23/07/2026 | 8,70% | 14,10% | ** |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) EUR | MIXTO AGRESIVO GLOBAL | 152,570000 | 23/07/2026 | 13,97% | 41,94% | ***** |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) USD | MIXTO AGRESIVO GLOBAL | 152,229635 | 23/07/2026 | 14,00% | 41,78% | ***** |